Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Fintel reports that on July 11, 2025, Raymond James initiated coverage of Vir Biotechnology (NasdaqGS:VIR) with a Outperform ...

A drug that targets two parts of the deadly Nipah virus protects against infection in hamsters. And once an animal is ...

Pepper the cat is at it again. After his hunting skills helped virologists identify the first jeilongvirus in the United ...

As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks.

The question now is not whether AI can reshape biotechnology, but how far it can take us. Enjoyed this article?

Scientists have identified dozens of human proteins that SARS-CoV-2, the virus that causes COVID-19, depends on to replicate ...

Virus Geeks is a data-driven Bio-Health Technology Company that develops health-centric initiatives to improve the quality of life through strategic partnerships across healthcare & biotechnology ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds - ticks.

New research has suggested that a virus that has typically been thought of as common and harmless may actually be associnrwd with an in creased risk of Par | Cell And Molecular Biology ...

Vir Biotechnology has demonstrated consistent progress in its clinical programs, particularly with the initiation of the ECLIPSE Phase III trials for hepatitis delta virus.